share_log

上海谊众(688091.SH)主要股东上海凯宝减持期届满未减持

Shanghai Yizhong (688091.SH), the main shareholder of Shanghai Kaibao (), did not reduce its holdings at the end of the holdings reduction period

Zhitong Finance ·  Nov 17, 2023 04:03

According to the Zhitong Finance App, Shanghai Yizhong (688091.SH) announced that Shanghai Kaibao Pharmaceutical Co., Ltd. (“Shanghai Kaibao”), which holds more than 5% of the company's shares, has not reduced its holdings in the company, and the current holdings reduction period has expired.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment